跳至主要内容
临床试验/CTRI/2009/091/000644
CTRI/2009/091/000644已完成3 期

A randomized trial to evaluate the effectiveness of antiretroviral therapy plus HIV primary care versus HIV primary care alone to prevent the sexual transmission of HIV-1 in Serodiscordant couples

ational Institute of Health USA0 个研究点目标入组 1,750 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
1,750

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Couples are defined as sexual partners same or opposite sex who are married have been
  • living together or consider each other a primary partner. They must have been together for a minimum of three months and at the time of study enrollment expect to maintain their relationship for the duration of the study.
  • Index Case:
  • -Positive HIV serology obtained within 60 days prior to enrollment
  • -Has a sexual partner (as defined above) who is not infected with HIV (documented by negative HIV serology) and who is willing to participate in the study.
  • -Plans to maintain a sexual relationship with the person who is enrolled in the study with them.
  • -Reports having sex (vaginal or anal) with partner at least 3 times in the last 3 months.
  • -If pregnant or breastfeeding during screening or at the time of enrollment, willing to be randomized to either arm of the study.
  • -The following conditions must be met for laboratory parameters within 60 days prior to enrollment:
  • CD4+ cell count of 350-550 cells/mm3
  • Hemoglobin > 7.5 g/dL
  • Platelet count > 50,000/µL.
  • AST (SGOT), ALT (SGPT), and alkaline phosphatase < 5 x ULN
  • Total bilirubin < 2.5 x ULN
  • Calculated creatinine clearance > 60 mL/min (use the Cockcroft and Gault method to calculate)
  • Absolute neutrophil count > 750 mm3 or 0.750 x 109/L
  • -Negative HIV serology within 14 days prior to enrollment.
  • -Has a sexual partner infected with HIV who is willing to participate in the study.
  • -Plans to maintain a sexual relationship with the person who is enrolled in the study with them.
  • -Reports having sex (vaginal or anal) with partner at least 3 times in the last 3 months.
  • Both Index Case and Partner:
  • -Men and women age > 18 years.
  • -Willing to disclose HIV test results to partner.
  • -Not intending to relocate out of the area for the duration of study participation and does not have a job or other obligations that may require long absences from the area.

排除标准

  • Index Case:
  • -Current or previous AIDS-defining illness (as defined in Appendix III).
  • -Current or previous use of any ART drugs
  • -Documented or suspected acute hepatitis within 30 days prior to enrollment, irrespective of AST (SGOT) and ALT (SGPT) values.
  • -Acute therapy for serious medical illnesses, chronic, acute, or recurrent infections in the opinion of the site investigator
  • -Radiation therapy or systemic chemotherapy, any immunomodulator or other investigational therapy, Active drug or alcohol use or dependence, Allergy/sensitivity to any study drugs.
  • Both Index Case and Partner:
  • -Reports a history of injection drug use within the last five years.
  • -Previous and/or current participant in an HIV vaccine study.
  • -Any condition that, in the opinion of the study staff, would make participation in the study unsafe
  • -Incarceration in a correctional facility

研究者

发起方
ational Institute of Health USA

相似试验